Copyright © 2012 Massimo Pancione et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. D. Cunningham, W. Atkin, H. J. Lenz et al., “Colorectal cancer,” The Lancet, vol. 375, no. 9719, pp. 1030–1047, 2010. View at Publisher · View at Google Scholar · View at Scopus
2. A. Tenesa and M. G. Dunlop, “New insights into the aetiology of colorectal cancer from genome-wide association studies,” Nature Reviews Genetics, vol. 10, no. 6, pp. 353–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
3. A. Jemal, M. M. Center, E. Ward, and M. J. Thun, “Cancer occurrence,” Methods in Molecular Biology, vol. 471, pp. 3–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
4. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2008,” CA Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
5. J. J. Y. Sung, J. Y. W. Lau, K. L. Goh et al., “Increasing incidence of colorectal cancer in Asia: implications for screening,” The Lancet Oncology, vol. 6, no. 11, pp. 871–876, 2005. View at Publisher · View at Google Scholar · View at Scopus
6. A. K. Rustgi, “The genetics of hereditary colon cancer,” Genes and Development, vol. 21, no. 20, pp. 2525–2538, 2007. View at Publisher · View at Google Scholar · View at Scopus
7. E. R. Fearon and B. Vogelstein, “A genetic model for colorectal tumorigenesis,” Cell, vol. 61, no. 5, pp. 759–767, 1990. View at Publisher · View at Google Scholar · View at Scopus
8. G. Smith, F. A. Carey, J. Beattie et al., “Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 14, pp. 9433–9438, 2002. View at Publisher · View at Google Scholar · View at Scopus
9. S. Ogino and A. Goel, “Molecular classification and correlates in colorectal cancer,” Journal of Molecular Diagnostics, vol. 10, no. 1, pp. 13–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
10. J. R. Jass, “Classification of colorectal cancer based on correlation of clinical, morphological and molecular features,” Histopathology, vol. 50, no. 1, pp. 113–130, 2007. View at Publisher · View at Google Scholar · View at Scopus
11. S. D. Markowitz and M. M. Bertagnolli, “Molecular basis of colorectal cancer,” The New England Journal of Medicine, vol. 361, no. 25, pp. 2404–2460, 2009. View at Publisher · View at Google Scholar · View at Scopus
12. J. Young, M. Jenkins, S. Parry et al., “Serrated pathway colorectal cancer in the population: genetic consideration,” Gut, vol. 56, no. 10, pp. 1453–1459, 2007. View at Publisher · View at Google Scholar · View at Scopus
13. S. Sharma, T. K. Kelly, and P. A. Jones, “Epigenetics in cancer,” Carcinogenesis, vol. 31, no. 1, pp. 27–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
14. M. Esteller, “Molecular origins of cancer: epigenetics in cancer,” The New England Journal of Medicine, vol. 358, no. 11, pp. 1148–1096, 2008. View at Publisher · View at Google Scholar · View at Scopus
15. R. Bonasio, S. Tu, and D. Reinberg, “Molecular signals of epigenetic states,” Science, vol. 330, no. 6004, pp. 612–616, 2010. View at Publisher · View at Google Scholar · View at Scopus
16. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
17. R. A. Beckman and L. A. Loeb, “Genetic instability in cancer: theory and experiment,” Seminars in Cancer Biology, vol. 15, no. 6, pp. 423–435, 2005. View at Publisher · View at Google Scholar · View at Scopus
18. M. S. Pino and D. C. Chung, “The chromosomal instability pathway in colon cancer,” Gastroenterology, vol. 138, no. 6, pp. 2059–2072, 2010. View at Publisher · View at Google Scholar · View at Scopus
19. C. R. Boland and A. Goel, “Microsatellite instability in colorectal cancer,” Gastroenterology, vol. 138, no. 6, pp. 2073–2087, 2010. View at Publisher · View at Google Scholar · View at Scopus
20. L. A. Loeb, C. F. Springgate, and N. Battula, “Errors in DNA replication as a basis of malignant changes,” Cancer Research, vol. 34, no. 9, pp. 2311–2321, 1974. View at Scopus
21. C. A. Klein, “Random mutations, selected mutations: a PIN opens the door to new genetic landscapes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 48, pp. 18033–18034, 2006. View at Publisher · View at Google Scholar · View at Scopus
22. M. Toyota, N. Ahuja, M. Ohe-Toyota, J. G. Herman, S. B. Baylin, and J. P. J. Issa, “CpG island methylator phenotype in colorectal cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 15, pp. 8681–8686, 1999. View at Publisher · View at Google Scholar · View at Scopus
23. C. R. Boland, N. L. Komarova, and A. Goel, “Chromosomal instability and cancer: not just one CINgle mechanism,” Gut, vol. 58, no. 2, pp. 163–164, 2009. View at Publisher · View at Google Scholar · View at Scopus
24. W. S. Samowitz, H. Albertsen, J. Herrick et al., “Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer,” Gastroenterology, vol. 129, no. 3, pp. 837–845, 2005. View at Publisher · View at Google Scholar · View at Scopus
25. J. P. J. Issa, L. Shen, and M. Toyota, “CIMP, at last,” Gastroenterology, vol. 129, no. 3, pp. 1121–1124, 2005. View at Publisher · View at Google Scholar · View at Scopus
26. K. Curtin, M. L. Slattery, and W. S. Samowitz, “CpG island methylation in colorectal cancer: past, present and future,” Pathology Research International, vol. 2011, Article ID 902674, 8 pages, 2011. View at Publisher · View at Google Scholar
27. Y. Xu, B. Hu, A. J. Choi, et al., “Unique DNA methylome profiles in CpG island methylator phenotype colon cancers,” Genome Research, vol. 22, no. 2, pp. 283–291, 2012.
28. T. Hinoue, D. J. Weisenberger, C. P. Lange, et al., “Genome-scale analysis of aberrant DNA methylation in colorectal cancer,” Genome Research, vol. 22, no. 2, pp. 271–282, 2012. View at Publisher · View at Google Scholar
29. B. P. Berman, D. J. Weisenberger, J. F. Aman, et al., “Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains,” Nature Genetics, vol. 44, no. 1, pp. 40–46, 2012.
30. J. P. Issa, “Colon cancer: it’s CIN or CIMP,” Clinical Cancer Research, vol. 14, no. 19, pp. 5939–5940, 2008.
31. I. M. Shih, T. L. Wang, G. Traverso et al., “Top-down morphogenesis of colorectal tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 5, pp. 2640–2645, 2001. View at Publisher · View at Google Scholar · View at Scopus
32. A. P. Feinberg, R. Ohlsson, and S. Henikoff, “The epigenetic progenitor origin of human cancer,” Nature Reviews Genetics, vol. 7, no. 1, pp. 21–33, 2006. View at Publisher · View at Google Scholar · View at Scopus
33. R. A. Irizarry, C. Ladd-Acosta, B. Wen et al., “The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores,” Nature Genetics, vol. 41, no. 2, pp. 178–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
34. J. E. Ohm, K. M. McGarvey, X. Yu et al., “A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing,” Nature Genetics, vol. 39, no. 2, pp. 237–242, 2007. View at Publisher · View at Google Scholar · View at Scopus
35. H. P. Mohammad, Y. Cai, K. M. McGarvey et al., “Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation,” Cancer Research, vol. 69, no. 15, pp. 6322–6330, 2009. View at Publisher · View at Google Scholar · View at Scopus
36. D. C. Snover, “Update on the serrated pathway to colorectal carcinoma,” Human Pathology, vol. 42, no. 1, pp. 1–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
37. B. Leggett and V. Whitehall, “Role of the serrated pathway in colorectal cancer pathogenesis,” Gastroenterology, vol. 138, no. 6, pp. 2088–2100, 2010. View at Publisher · View at Google Scholar · View at Scopus
38. S. M. Dieter, C. R. Ball, C. M. Hoffmann, et al., “Distinct types of tumor-initiating cells form human colon cancer tumors and metastases,” Cell Stem Cell, vol. 9, no. 4, pp. 375–365, 2011.
39. J. Terzic, S. Grivennicov, E. Karin, and M. Karin, “Inflammation and colon cancer,” Gastroenterology, vol. 138, no. 6, pp. 2101–2114, 2010. View at Publisher · View at Google Scholar
40. A. P. Feinberg and B. Vogelstein, “Hypomethylation distinguishes genes of some human cancers from their normal counterparts,” Nature, vol. 301, no. 5895, pp. 89–92, 1983. View at Scopus
41. R. J. Taft, K. C. Pang, T. R. Mercer, M. Dinger, and J. S. Mattick, “Non-coding RNAs: regulators of disease,” Journal of Pathology, vol. 220, no. 2, pp. 126–139, 2010. View at Publisher · View at Google Scholar · View at Scopus
42. A. Portela and M. Esteller, “Epigenetic modifications and human disease,” Nature Biotechnology, vol. 28, no. 10, pp. 1057–1068, 2010. View at Publisher · View at Google Scholar · View at Scopus
43. M. Pancione, L. Sabatino, A. Fucci et al., “Epigenetic silencing of peroxisome proliferator- activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome,” PLoS ONE, vol. 5, no. 12, article e14229, 2010. View at Publisher · View at Google Scholar · View at Scopus
44. R. K. Chodavarapu, S. Feng, Y. V. Bernatavichute et al., “Relationship between nucleosome positioning and DNA methylation,” Nature, vol. 466, no. 7304, pp. 388–392, 2010. View at Publisher · View at Google Scholar · View at Scopus
45. K. N. Harikrishnan, M. Z. Chow, E. K. Baker et al., “Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing,” Nature Genetics, vol. 37, no. 3, pp. 254–264, 2005. View at Publisher · View at Google Scholar · View at Scopus
46. D. Reisman, S. Glaros, and E. A. Thompson, “The SWI/SNF complex and cancer,” Oncogene, vol. 28, no. 14, pp. 1653–1668, 2009. View at Publisher · View at Google Scholar · View at Scopus
47. L. Ho, J. L. Ronan, J. Wu et al., “An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 13, pp. 5181–5186, 2009. View at Publisher · View at Google Scholar · View at Scopus
48. P. P. Medina and M. Sanchez Cespedes, “Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer,” Epigenetics, vol. 3, no. 2, pp. 64–68, 2008. View at Scopus
49. D. N. Reisman, M. W. Strobeck, B. L. Betz et al., “Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression,” Oncogene, vol. 21, no. 8, pp. 1196–1207, 2002. View at Publisher · View at Google Scholar · View at Scopus
50. A. K. C. Wong, F. Shanahan, Y. Chen et al., “BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines,” Cancer Research, vol. 60, no. 21, pp. 6171–6177, 2000. View at Scopus
51. S. Bultman, T. Gebuhr, D. Yee et al., “A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes,” Molecular Cell, vol. 6, no. 6, pp. 1287–1295, 2000. View at Publisher · View at Google Scholar · View at Scopus
52. T. Watanabe, S. Semba, and H. Yokozaki, “Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells,” British Journal of Cancer, vol. 104, no. 1, pp. 146–154, 2011. View at Publisher · View at Google Scholar · View at Scopus
53. E. Sánchez-Tilló, A. Lázaro, R. Torrent et al., “ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1,” Oncogene, vol. 29, no. 24, pp. 3490–3500, 2010. View at Publisher · View at Google Scholar · View at Scopus
54. N. Yamamichi, K. I. Inada, M. Ichinose et al., “Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state,” Cancer Research, vol. 67, no. 22, pp. 10727–10735, 2007. View at Publisher · View at Google Scholar · View at Scopus
55. C. G. Sansam and C. W. M. Roberts, “Epigenetics and cancer: altered chromatin remodeling via Snf5 loss leads to aberrant cell cycle regulation,” Cell Cycle, vol. 5, no. 6, pp. 621–624, 2006. View at Scopus
56. N. Sévenet, A. Lellouch-Tubiana, D. Schofield et al., “Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations,” Human Molecular Genetics, vol. 8, no. 13, pp. 2359–2368, 1999. View at Scopus
57. J. A. Biegel, J. Y. Zhou, L. B. Rorke, C. Stenstrom, L. M. Wainwright, and B. Fogelgren, “Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors,” Cancer Research, vol. 59, no. 1, pp. 74–79, 1999. View at Scopus
58. C. W. M. Roberts and J. A. Biegel, “The role of SMARCB1/INI1 in development of rhabdoid tumor,” Cancer Biology and Therapy, vol. 8, no. 5, pp. 412–416, 2009. View at Scopus
59. A. Remo, C. Zanella, E. Molinari, et al., “Rhabdoid carcinoma of the colon, a distinct entity with a very aggressive behaviour. A case report, associated with a polyposis coli and review of the Literature,” International Journal of Surgical Pathology, vol. 2, no. 20, pp. 185–190, 2012.
60. M. Pancione, A. Di Blasi, L. Sabatino et al., “A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation,” Human Pathology, vol. 42, no. 7, pp. 1047–1052, 2011. View at Publisher · View at Google Scholar · View at Scopus
61. H. R. Moinova, W. D. Chen, L. Shen et al., “HLTF gene silencing in human colon cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 7, pp. 4562–4567, 2002. View at Publisher · View at Google Scholar · View at Scopus
62. S. Popat, R. Hubner, and R. S. Houlston, “Systematic review of microsatellite instability and colorectal cancer prognosis,” Journal of Clinical Oncology, vol. 23, no. 3, pp. 609–618, 2005. View at Publisher · View at Google Scholar · View at Scopus
63. A. Lugli, I. Zlobec, P. Minoo et al., “Prognostic significance of the wnt signalling pathway molecules APC, β-catenin and E-cadherin in colorectal cancer—a tissue microarray-based analysis,” Histopathology, vol. 50, no. 4, pp. 453–464, 2007. View at Publisher · View at Google Scholar · View at Scopus
64. R. Kalluri and R. A. Weinberg, “The basics of epithelial-mesenchymal transition,” Journal of Clinical Investigation, vol. 119, no. 6, pp. 1420–1428, 2009. View at Publisher · View at Google Scholar · View at Scopus
65. J. G. Clohessy and P. P. Pandolfi, “β-tting on p63 as a Metastatic Suppressor,” Cell, vol. 137, no. 1, pp. 28–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
66. G. Moreno-Bueno, H. Peinado, P. Molina et al., “The morphological and molecular features of the epithelial-to-mesenchymal transition,” Nature Protocols, vol. 4, no. 11, pp. 1591–1613, 2009. View at Scopus
67. M. Guarino, B. Rubino, and G. Ballabio, “The role of epithelial-mesenchymal transition in cancer pathology,” Pathology, vol. 39, no. 3, pp. 305–318, 2007. View at Publisher · View at Google Scholar · View at Scopus
68. M. J. Larriba, J. Casado-Vela, N. Pendás-Franco et al., “Novel snail1 target proteins in human colon cancer identified by proteomic analysis,” PLoS ONE, vol. 5, no. 4, article e10221, 2010. View at Publisher · View at Google Scholar · View at Scopus
69. G. Moreno-Bueno, E. Cubillo, D. Sarrió et al., “Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for snail, Slug, and E47 Factors in epithelial- mesenchymal transition,” Cancer Research, vol. 66, no. 19, pp. 9543–9556, 2006. View at Publisher · View at Google Scholar · View at Scopus
70. M. Amano, M. Nakayama, and K. Kaibuchi, “Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity,” Cytoskeleton, vol. 67, no. 9, pp. 545–554, 2010. View at Publisher · View at Google Scholar · View at Scopus
71. P. Ortega, A. Morán, C. De Juan et al., “Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability,” Clinical Cancer Research, vol. 14, no. 4, pp. 995–1001, 2008. View at Publisher · View at Google Scholar · View at Scopus
72. H. Suzuki, N. Masuda, T. Shimura et al., “Nuclear β-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma,” Anticancer Research, vol. 28, no. 3, pp. 1821–1830, 2008. View at Scopus
73. D. Horst, S. Reu, L. Kriegl, J. Engel, T. Kirchner, and A. Jung, “The intratumoral distribution of nuclear β-catenin is a prognostic marker in colon cancer,” Cancer, vol. 115, no. 10, pp. 2063–2070, 2009. View at Publisher · View at Google Scholar · View at Scopus
74. M. Pancione, N. Forte, A. Fucci et al., “Prognostic role of β-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer,” Human Pathology, vol. 41, no. 6, pp. 867–876, 2010. View at Publisher · View at Google Scholar · View at Scopus
75. J. García-Solano, P. Conesa-Zamora, J. Trujillo-Santos, et al., “Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma,” Human Pathology, vol. 43, no. 7, pp. 1094–1102, 2012.
76. M. S. Pino, H. Kikuchi, M. Zeng et al., “Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability,” Gastroenterology, vol. 138, no. 4, pp. 1406–1417, 2010. View at Publisher · View at Google Scholar · View at Scopus
77. G. H. Kang, “Four molecular subtypes of colorectal cancer and their precursor lesions,” Archives of Pathology and Laboratory Medicine, vol. 135, no. 6, pp. 698–703, 2011. View at Scopus
78. J. M. Bae, M. J. Kim, J. H. Kim et al., “Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status,” Virchows Archiv, vol. 459, no. 1, pp. 55–63, 2011. View at Publisher · View at Google Scholar · View at Scopus
79. R. N. Jorissen, P. Gibbs, M. Christie et al., “Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer,” Clinical Cancer Research, vol. 15, no. 24, pp. 7642–7651, 2009. View at Publisher · View at Google Scholar · View at Scopus
80. J. J. Smith, N. G. Deane, F. Wu et al., “Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer,” Gastroenterology, vol. 138, no. 3, pp. 958–968, 2010. View at Publisher · View at Google Scholar · View at Scopus
81. A. Loboda, M. V. Nebozhyn, J. W. Watters et al., “EMT is the dominant program in human colon cancer,” BMC Medical Genomics, vol. 4, article 9, 2011. View at Publisher · View at Google Scholar · View at Scopus
82. F. Prall, “Tumour budding in colorectal carcinoma,” Histopathology, vol. 50, no. 1, pp. 151–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
83. E. Karamitopoulou, A. Lugli, I. Panayiotides et al., “Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer,” Histopathology, vol. 57, no. 2, pp. 233–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
84. I. Zlobec, F. Molinari, V. Martin et al., “Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients,” World Journal of Gastroenterology, vol. 16, no. 38, pp. 4823–4831, 2010. View at Publisher · View at Google Scholar · View at Scopus
85. I. Zlobec and A. Lugli, “Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget,” Oncotarget, vol. 1, no. 7, pp. 651–661, 2010. View at Scopus
86. W. S. Samowitz, C. Sweeney, J. Herrick et al., “Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers,” Cancer Research, vol. 65, no. 14, pp. 6063–6070, 2005. View at Publisher · View at Google Scholar · View at Scopus
87. M. S. Kim, J. Lee, and D. Sidransky, “DNA methylation markers in colorectal cancer,” Cancer and Metastasis Reviews, vol. 29, no. 1, pp. 181–206, 2010. View at Publisher · View at Google Scholar · View at Scopus
88. W. M. Grady and J. M. Carethers, “Genomic and epigenetic instability in colorectal cancer pathogenesis,” Gastroenterology, vol. 135, no. 4, pp. 1079–1099, 2008. View at Publisher · View at Google Scholar · View at Scopus
89. J. J. L. Wong, N. J. Hawkins, R. L. Ward, and M. P. Hitchins, “Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer,” Modern Pathology, vol. 24, no. 3, pp. 396–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
90. I. B. Georgiades, L. J. Curtis, R. M. Morris, C. C. Bird, and A. H. Wyllie, “Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability,” Oncogene, vol. 18, no. 56, pp. 7933–7940, 1999. View at Scopus
91. D. R. English, J. P. Young, J. A. Simpson et al., “Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 7, pp. 1774–1780, 2008. View at Publisher · View at Google Scholar · View at Scopus
92. L. S. Rozek, C. M. Herron, J. K. Greenson et al., “Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 3, pp. 838–843, 2010. View at Publisher · View at Google Scholar · View at Scopus
93. S. Ogino, K. Nosho, G. J. Kirkner et al., “CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer,” Gut, vol. 58, no. 1, pp. 90–96, 2009. View at Publisher · View at Google Scholar · View at Scopus